Topic: Schering-Plough Corporation
Recently published in the New England Journal of Medicine, the largest prospective study of chronic hepatitis C virus (HCV) treatments Pegetron and Pegasys RBV (R) found both treatments equal in achieving sustained viral response. (i) The study also found that Pegetron had ...
CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday.The findings, from a 3,000-patient comparative effectiveness study, are meant to help guide doctors' decisions about which treatments ...
Patients that received a 48-week boceprevir regimen achieved a 75 percent SVR rate, twice the efficacy rate provided by current standard therapies . KIRKLAND, QC, May 26 /CNW/ - Schering-Plough Canada announced today that final results of the HCV SPRINT-1 (HCV Serine ...
Schering-Plough, the drug company known for its cholesterol treating drugs VytorinT and Zetia? recently announced a merger with Merck, a drug company known for asthma and allergy medicine Singulair?. For example, Schering-Plough makes Pegintron (a pegylated interferon for treating chronic hepatitis C) ...
First Large Study Comparing Leading Hepatitis C Therapies Provides Important Insights to Help Guide Clinical Practice Final results of the IDEAL study, the first large, randomized, clinical study comparing the leading therapies for chronic hepatitis C, were presented today at the 43rd ...
Schering-Plough Corporation , a leader in advancing the science and treatment of chronic hepatitis C virus (HCV) infection, announced today that final results of the IDEAL study as well as from several other clinical studies with PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, ...
From Around the Web
Video Gallery
-
Nomad Stories Fred Hassan, Schering-Plough Corp
Nomad Stories Fred Hassan, Schering-Plough Corp2008-10-28 -
July 15 Biz Minute
Drugmakers Merck & Co. and Schering-Plough Corp. said today they will ...2009-07-15 -
Robert Spiegel - SVP & CMO Schering-Plough
Prior to his current position, Robert was Senior Vice President ...2009-07-27
